Form 8-K - Current report:
SEC Accession No. 0001144204-13-004606
Filing Date
2013-01-30
Accepted
2013-01-29 20:12:55
Documents
6
Period of Report
2013-01-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v333302_8k.htm 8-K 21799
2 EXHIBIT 10.1 v333302_ex10-1.htm EX-10.1 294504
3 EXHIBIT 10.2 v333302_ex10-2.htm EX-10.2 137154
4 EXHIBIT 10.3 v333302_ex10-3.htm EX-10.3 82444
5 EXHIBIT 99.1 v333302_ex99-1.htm EX-99.1 12641
6 GRAPHIC tlogo.jpg GRAPHIC 17447
  Complete submission text file 0001144204-13-004606.txt   574228
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 000-17263 | Film No.: 13556766
SIC: 2836 Biological Products, (No Diagnostic Substances)